DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel (CMP) Testing Market Analysis by Disease Type (Diabetes, Kidney Disease, Liver Disease), by End User (Point Of Contact (PoC), Laboratories), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global comprehensive metabolic panel (CMP) testing market size is estimated to be USD 12.5 billion in 2021 and is expected to witness a CAGR of 8.42% to 2029
Growth in awareness concerning early diagnosis and treatment of diseases is a key driver for the growth of the global comprehensive metabolic panel (CMP) testing market.
Additionally, rise in geriatric population base globally and increase in global cases of chronic diseases in the comprehensive metabolic panel (CMP) testing market are some of the other drivers propelling the market growth. Nevertheless, absence of skilled professionals to operate the testing panels and strict regulatory guidelines are expected to restrain the global market growth.
By Disease Type
In 2021, the kidney disease segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
This is attributed to the increase in prevalence of kidney disease and maximum application of analytes worldwide. Diabetes segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing cases of diabetes globally which is driving the comprehensive metabolic panel testing market.
By End User
In 2021, the laboratories segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
This is attributed to the easy accessibility, increasing market penetration, better usage worldwide. Point of contact (PoC) segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing demand from consumers for improved and efficient diagnosis, laboratory testing of CMP is expected to maintain the leading position in the market.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the high disease liability, presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government, accessibility of technological advanced products in the region.
Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the economic development in the region, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and availability of skilled labour forces at economic costs, are the major factors in this region.
Competitor Insights
The leading players operating in the comprehensive metabolic panel (CMP) testing industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
Companies Mentioned
- Abbott Laboratories (U.S.)
- Quest Diagnostics (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Healthcare Limited (Australia)
- Unipath Lab (U.S.)
- Synlab Group (Germany)
- Abaxis Inc. (Zoetis) (U.S.)
- Tcg Corp. (U.S.)
- Scion Lab Services
- LLC (U.S.)
- Centogene (Germany)
Comprehensive Metabolic Panel (CMP) Testing Market, By Disease Type (Revenue, USD Billion, 2021 – 2029)
- Diabetes
- Kidney Disease
- Liver Disease
- Others
Comprehensive Metabolic Panel (CMP) Testing Market, By End User (Revenue, USD Billion, 2021 – 2029)
- Point of Contact (PoC)
- Laboratories
Comprehensive Metabolic Panel (CMP) Testing Market, By Region (Revenue, USD Billion, 2021 – 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/hi1zq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
